Bristol-Myers Squibb Co
NYSE:BMY
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
39.46
59.94
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
BMY Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BMY is 60.56 USD with a low forecast of 33.43 USD and a high forecast of 76.65 USD.
BMY Last Price Targets
Bristol-Myers Squibb Co
The latest public price target was made on Nov 12, 2024 by Evan Seigerman from BMO Capital , who expects BMY stock to rise by 6% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Bristol-Myers Squibb Co
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 4 years is 11%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMY's stock price target?
Price Target
60.56
USD
According to Wall Street analysts, the average 1-year price target for BMY is 60.56 USD with a low forecast of 33.43 USD and a high forecast of 76.65 USD.
What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
0%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 13%. The projected CAGR for the next 4 years is 0%.
What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 4 years is 11%.
What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 23%. The projected CAGR for the next 4 years is 14%.